Effectiveness of Different Isolation Periods for COVID-19
Effectiveness of Quarantine and Isolation for Reducing Transmission of COVID-19 and Other Respiratory Infections, as Well as Impacting Other Individual and Social Outcomes in Non-Health Care Community-Based Settings
Project Status:Complete
Knowledge User(s)
Public Health Agency of Canada
Funding Source(s)
- Public Health Agency of Canada
Project Objectives
To determine (1) the effectiveness of different lengths of quarantine (e.g., > 10 days, ≤ 10days) in reducing transmission of COVID-19 in non-health care community-based settings; (2) the effectiveness of different lengths of isolation (e.g., > 10 days, ≤ 10days) in reducing transmission of COVID-19 in non-health care community-based settings; (3) the effectiveness of different lengths of quarantine (e.g., > 10 days, ≤ 10days) in reducing transmission of non-COVID-19 respiratory illnesses (e.g., influenza, respiratory syncytial virus (RSV)) in non-health care community-based settings; (4) the effectiveness of different lengths of isolation (e.g., > 10 days, ≤ 10days) in reducing transmission of non-COVID-19 respiratory illnesses (e.g., influenza, respiratory syncytial virus (RSV)) in non-health care community-based settings; (5) the impact of quarantine on other individual and societal outcomes (e.g., mental health, financial circumstances) in non-health care community-based settings; and (6) the impact of isolation on other individual and societal outcomes (e.g., mental health, financial circumstances) in non-health care community-based settings.
Research Approach
Living Evidence Synthesis
Project Lead(s)
Simon Bacon
Dr. Bacon’s research deals with the impact of health behaviours and lifestyle (e.g., physical activity, diet, weight management, stress) on the development and progression of chronic diseases (e.g., obesity, cardiovascular disease, COVID-19). He utilises multiple methodologies including epidemiological, psychophysiological, evidence syntheses, and behavioural trials designs. Currently, Dr. Bacon is the FRQS co-Chair in Artificial Intelligence and Digital Health for Health Behaviour Change and the CIHR SPOR Chair in Innovative, Patient-Oriented, Behavioural Clinical Trials. He is also a fellow of the Obesity Society, the Canadian Cardiovascular Society, and the Academy of Behavioral Medicine Research. In addition to Concordia, Dr. Bacon is co-director of the Montreal Behavioural Medicine Centre (www.mbmc-cmcm.ca), a researcher at the Centre intégré universitaire de santé et de services sociaux du Nord-de-l’Île-de-Montréal (CIUSSS-NIM), and co-leads the International Behavioural Trials Network (www.IBTNetwork.org) and the CIHR funded Canadian Behavioural Interventions and Trials Network (www.CBITN.ca).
Simon Bacon
Montreal Behavioural Medicine Centre, Concordia University
Dr. Bacon’s research deals with the impact of health behaviours...